MIP-3alpha and MIP-1alpha rapidly mobilize dendritic cell precursors into the peripheral blood.
Acquisition of dendritic cells (DCs) or DC precursors in vitro is critical for DC-based immunotherapy. We reported previously that administration of MIP-1alpha mobilized a population of F4/80(-)B220(-)CD11c+ DC precursors into peripheral blood by the expression of CCR1 and CCR5. In this study, we identified a new subset of CCR6+CCR1(-)CCR5(-)B220(-)CD11c(+) cells in MIP-1alpha-administered mice. When cultured with GM-CSF, IL-4, and TNF-alpha, these cells differentiated into mature DCs, possessing the typical morphologic characteristics, phenotypes, and antigen-presenting function (termed CCR6+ DC precursors). Although it did not directly drive the CCR6+ DC precursors, MIP-1alpha could recruit a population of F4/80+CD11c(-) monocyte/macrophage-producing MIP-3alpha in the peripheral blood to mobilize a CCR6+ DC precursor subset of B220(-)CD11c+ DC precursors. Importantly, exogenous administration of MIP-3alpha significantly enhanced MIP-1alpha-induced mobilization of DC precursors. Moreover, these MIP-3alpha- and MIP-1alpha-mobilized DC precursors could be prepared for a DC vaccine capable of eliciting CTL responses to tumor cells, leading to tumor rejection in vitro and in vivo. Taken together, this study further demonstrates the mechanism of DC precursor mobilization induced by MIP-1alpha; that is, besides mobilizing DC precursors with CCR1 and CCR5 expressions, MIP-1alpha recruited F4/80+CD11c(-) monocyte/macrophage-producing MIP-3alpha, which finally mobilized the CCR6+ DC precursor subset to amplify the B220(-)CD11c+ DC precursor population. Furthermore, combined administration of MIP-3alpha and MIP-1alpha may be an efficient strategy for collecting a large number of DCs appropriate for immunotherapy.
He
Shan
S
Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
Cao
Qi
Q
Yoneyama
Hiroyuki
H
Ge
Hailiang
H
Zhang
Yi
Y
Zhang
Yanyun
Y
D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D002478:Cells, Cultured; D054418:Chemokine CCL20 / Q000502:physiology*; D054405:Chemokine CCL3 / Q000502:physiology*; D002633:Chemotaxis; D003713:Dendritic Cells / Q000276:immunology*; D005260:Female; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism; D008264:Macrophages / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D008546:Melanoma, Experimental / Q000276:immunology* / Q000378:metabolism / Q000628:therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009000:Monocytes / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D016133:Polymerase Chain Reaction; D054389:Receptors, CCR1 / Q000502:physiology; D019713:Receptors, CCR5 / Q000502:physiology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014611:Vaccination
C515301:Ccr1 protein, mouse; D054418:Chemokine CCL20; D054405:Chemokine CCL3; D054389:Receptors, CCR1; D019713:Receptors, CCR5; D007371:Interferon-gamma
Mol Med. 1996 Sep;2(5):545-55
8898371
J Immunol. 2000 Apr 15;164(8):4105-10
10754304
Nature. 1998 Mar 19;392(6673):245-52
9521319
J Natl Cancer Inst. 2004 Feb 4;96(3):201-9
14759987
Cell. 1999 Nov 12;99(4):351-4
10571177
J Leukoc Biol. 2003 Sep;74(3):448-55
12949249
J Immunol. 1999 Nov 1;163(9):4715-20
10528169
Nat Immunol. 2003 Feb;4(2):154-60
12524535
Blood. 2007 Aug 1;110(3):921-7
17403919
Vaccine. 2006 Apr 5;24(15):2860-8
16443309
Curr Opin Investig Drugs. 2006 Dec;7(12):1052-61
17209522
J Leukoc Biol. 2008 Mar;83(3):439-46
17991763
Curr Med Chem. 2005;12(15):1783-800
16029147
Arthritis Res. 2002;4 Suppl 3:S183-8
12110138
J Exp Med. 1997 Sep 15;186(6):825-35
9294137
Transplantation. 2002 Jan 15;73(1 Suppl):S7-11
11810053
Immunol Lett. 2000 Sep 15;74(1):5-10
10996622
Front Biosci. 2008 May 01;13:3966-74
18508490
Blood. 1998 Jul 1;92(1):118-28
9639507
Immunol Rev. 2000 Oct;177:134-40
11138771
Curr Opin Allergy Clin Immunol. 2003 Dec;3(6):467-73
14612671
Int J Cancer. 1999 May 17;81(4):650-7
10225458
J Exp Med. 1997 Jun 2;185(11):1959-68
9166425
Front Biosci. 2008 Jan 01;13:2238-52
17981706
Blood. 1997 Dec 15;90(12):4842-53
9389701
J Clin Invest. 2002 Jun;109(12):1519-26
12070296
Stem Cells. 1996 Sep;14(5):501-7
8888491
J Exp Med. 2001 Jan 1;193(1):35-49
11136819
Int J Cancer. 1997 Sep 17;72(6):1045-55
9378539
Curr Opin Immunol. 2005 Apr;17(2):163-9
15766676
J Exp Med. 1998 Jul 20;188(2):373-86
9670049
Science. 1999 Dec 10;286(5447):2098-102
10617422
J Immunol. 2006 Dec 1;177(11):8226-33
17114500